Abivax (ABVX) Tax Rate (2025 - 2026)
Abivax (ABVX) posted quarterly Tax Rate of 0.47% for Q1 2026, down 93.79% quarter-over-quarter from 7.62% in Q4 2025.
Powered by 
Analysis
Abivax (ABVX) Tax Rate (2025 - 2026) Analysis & Trends
Abivax's Tax Rate history runs 2 years deep, the most recent figure standing at 0.47% for Q1 2026.
- In Q1 2026, Tax Rate changed N/A year-over-year to 0.47%; the TTM figure through Mar 2026 stood at 1.85% (changed N/A YoY), while the FY2025 annual figure was 1.76%, changed N/A from the prior year.
- Tax Rate for Q1 2026 stood at 0.47%, down from 7.62% in the prior quarter.
- The five-year high for Tax Rate was 7.62% in Q4 2025, with the low at 0.47% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -16.71% |
| 10 | Abivax | 7.97 Bn | 7.97 Bn | - | 0.47% |